Babyquest Cryobank Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.23%
- Profit Growth 6.58%
- Ebitda 8.20%
- Net Worth -29.85%
- Total Assets -6.30%
About Babyquest Cryobank
Babyquest Cryobank Private Limited (BCPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2008 and has a history of 16 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Cryos International - India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dilip Patil and Sangeeta Patil serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100MH2008PTC184503
- Company No.
184503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2008
- Date of AGM
27 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Babyquest Cryobank?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Patil  | Director | 10-Jul-2008 | Current |
| Sangeeta Patil | Director | 10-Jul-2008 | Current |
Financial Performance of Babyquest Cryobank.
Babyquest Cryobank Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 13.23% increase. The company also saw a slight improvement in profitability, with a 6.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Babyquest Cryobank?
In 2017, Babyquest Cryobank had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trivector Biomed LlpDilip Patil and Sangeeta Patil are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Babyquest Cryobank?
Babyquest Cryobank has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Babyquest Cryobank, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Babyquest Cryobank's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.